Immersive Rehab & VR Therapy
Virtual and augmented reality are transforming healthcare with innovative digital treatments for physical and psychological healing. These carefully selected companies are at the forefront of creating immersive technologies that offer effective alternatives to traditional therapies, poised to benefit from growing clinical acceptance.
Your Basket's Financial Footprint
Summary of total market capitalisation and dominance by large-cap constituents for the Immersive Rehab & VR Therapy basket.
- Large-cap dominance typically implies lower volatility and more stable, market-like returns versus small-cap, high-volatility baskets.
- Useful as a core holding for broad exposure rather than a speculative, high-growth position in your portfolio.
- Expect steady, long-term value accumulation rather than rapid, short-term gains; growth tends to be gradual.
IMMR: $229.37M
VRAR: $33.49M
DHAI: $6.46M
- Other
About This Group of Stocks
Our Expert Thinking
These companies represent the exciting intersection of healthcare and cutting-edge technology. By focusing on businesses developing VR/AR platforms for rehabilitation, pain management, and psychological treatment, this collection targets a high-growth niche that's gaining momentum through increasing FDA approvals and clinical adoption.
What You Need to Know
This group offers exposure to the rising demand for non-pharmacological, data-driven therapies that can be personalized to patient needs. As digital therapeutics gain insurance reimbursement and broader acceptance from medical institutions, these pioneering companies are well-positioned to capture significant market growth.
Why These Stocks
We've handpicked companies with demonstrated expertise in medical VR/AR hardware, haptic technology, and specialized software cleared for clinical use. Each selection represents a different aspect of the immersive therapy ecosystem, from the technology creators to those already implementing solutions in healthcare settings.
Why You'll Want to Watch These Stocks
Medical Revolution Happening Now
VR/AR therapy is gaining rapid clinical acceptance and FDA approvals, creating a perfect entry point for investors before mainstream adoption fully takes hold.
Beyond Traditional Medicine
These companies offer an alternative to pharmaceutical approaches with fewer side effects, tapping into growing patient demand for non-invasive, personalized treatment options.
Multiple Growth Catalysts Ahead
Expanding insurance reimbursement, increasing clinical adoption, and a growing body of efficacy research are all converging to potentially accelerate this sector's growth.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Retail Showdown: Amazon vs Big-Box Giants 2025
Amazon is launching its largest physical store yet, directly challenging established big-box retailers like Walmart and Target. This strategic pivot could boost companies that support physical retail, including shopping center REITs and providers of in-store technology, as the competition for brick-and-mortar shoppers intensifies.
Modern Grocery Stocks | Berkshire Exits Kraft Heinz
Berkshire Hathaway's plan to sell its major stake in Kraft Heinz signals a larger market trend against legacy packaged foods. This creates an investment opportunity in companies better aligned with modern consumer demands for healthier and private-label options.
Digital Ad Disruption | Meta FTC Legal Challenge
The Federal Trade Commission is appealing a ruling in its antitrust case against Meta, reigniting a legal battle over the company's social media dominance. This legal challenge could disrupt the digital advertising landscape, creating potential growth opportunities for Meta's competitors.